Granted
The Veteran's prostate cancer residuals were granted a rating of 30 percent effective August 31, 2023.
The deciding factor: The evidence demonstrated marked obstructive symptomatology with post void residuals greater than 150 cc beginning August 31, 2023.
- Claimed conditions
- prostate cancer residuals
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 30%
- Decision date
- October 30, 2025
- Citation
- A25094267
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.